Recent Finacing
Recent Raise
Artizan Biosciences uses its proprietary IgA-SEQ platform to identify disease-driving gut bacteria and develop pathogen-targeted therapies for inflammatory bowel disease, operating gnotobiotic labs in New Haven and Durham.
